A Phase 3 Trial of Brepocitinib in Dermatomyositis. Vleugels RA, Paik JJ, Bauer Ventura I, Mangold AR, et al. N Engl J Med 2026 Mar 28. doi: 10.1056/NEJMoa2503531.

Read + Share

Amedeo Smart

Independent Medical Education

Vleugels RA, Paik JJ, Bauer Ventura I, Mangold AR, et al. A Phase 3 Trial of Brepocitinib in Dermatomyositis. N Engl J Med 2026 Mar 28. doi: 10.1056/NEJMoa2503531.
PMID: 41910335